Manufacturers Falling Down On Quality Data Collection And Analysis, FDA Warns
This article was originally published in The Gray Sheet
Executive Summary
Capturing and analyzing product quality data is a stumbling block for many firms, but the problem can be addressed with good procedures and effective monitoring of quality data sources, FDA officials explain.